Family holds Ozempic responsible for tragic suicide of type 2 diabetes patient

Soniya
California Man
California man's suicide raises concerns about Ozempic and mental health. (Image via Unsplash/Alexander Grey)

In a heart-wrenching incident that has raised concerns about the widely prescribed diabetes medication Ozempic, an unnamed California man (name withheld to protect his children) has died by suicide.

The family of the deceased claims that Ozempic, a drug used to manage type 2 diabetes, played a significant role in his tragic decision to take his own life.

According to the man's fiancee, Carolyn Hasty, her partner experienced a noticeable change in his personality soon after starting his Ozempic treatment. She described him as charismatic and outgoing, but during his time on the medication, he became quiet and withdrawn.

Hasty firmly believes that the mental health risks associated with this medication were the catalyst for his suicidal thoughts.


Family alleges drug link to type 2 diabetes patient's tragic suicide

Type 2 diabetes medication's potential impact on mental health (Image via Unsplash/Danilo Alvesd)
Type 2 diabetes medication's potential impact on mental health (Image via Unsplash/Danilo Alvesd)

Merlene Hall, the man's sister, shares Hasty's concerns and blames the drug for her brother's untimely death.

Hall asserts that the medication pushed her brother towards self-destructive thoughts and actions.


Novo Nordisk denies connection between Ozempic and suicide risk

Dark Side of Diabetes Medication (Image via Unsplash / Towfique Barbhuiya)
Dark Side of Diabetes Medication (Image via Unsplash / Towfique Barbhuiya)

In a statement to NBC News, Novo Nordisk expressed confidence in the safety of Ozempic.

They emphasized that available clinical studies and real-world data do not support claims of an elevated suicide risk associated with the drug. Furthermore, the statement pointed out that no instances of suicide or self-injury were reported in completed clinical trials.

Notably, this is not the first time that Ozempic and similar medications have been linked to mental health concerns. The European Medicines Agency had previously expanded its investigation into Novo Nordisk following the receipt of 150 reports implicating self-injury and suicidal thoughts associated with these drugs.

It's approved by the U.S. Food and Drug Administration for the treatment of type 2 diabetes and is administered through injections in the thigh, stomach or arm. However, it does not carry the same warning label for depression or suicidal thoughts as similar medications like Saxenda and Wegovy.

Those drugs include warnings to monitor patients for signs of depression or suicidal ideation. Wegovy specifically advises against use in individuals with a history of suicide attempts or active suicidal thoughts.


Concerns about Ozempic and mental health in tragic suicide case

Lack of adequate information and monitoring (Image via Unsplash/Volodymyr Hryshchenko)
Lack of adequate information and monitoring (Image via Unsplash/Volodymyr Hryshchenko)

The family of the deceased firmly believes that healthcare providers did not adequately inform their loved one about the potential impact of Ozempic on mental health, especially given his previous struggles with anxiety and depression.

They argue that he should never have been prescribed the medication, or at the very least, should have been closely monitored while taking it. While the family holds Ozempic responsible for their tragic loss, they also acknowledge that the drug may offer benefits to many others with type 2 diabetes.


Discrepancies in warning labels for diabetes medications

The case of the California man highlights the need for thorough risk assessment and personalized monitoring when prescribing medications like Ozempic. Healthcare providers must ensure that patients are well-informed about potential side effects, especially those related to mental health.

As investigations continue into the link between the drug and mental health complications, it has become essential for regulatory agencies, healthcare providers and drug manufacturers to collaborate to ensure that the medications prescribed are safe and suitable for each patient.

Prescribing practices and warning labels should undergo periodic evaluations to reflect the most up-to-date understanding of the potential risks and benefits associated with these drugs.


If you or someone you know is in crisis, please seek help from a mental health professional or contact a helpline immediately.

App download animated image Get the free App now